Diana Brainard, incoming AlloVir CEO

One of the mas­ter­minds be­hind remde­sivir, Gilead­'s Di­ana Brainard jumps ship to an­tivi­ral T cell play­er AlloVir

As one of the star­tups tapped to join David Hal­lal’s dis­rup­tive man­u­fac­tur­ing out­fit El­e­vate­Bio in the Boston area, AlloVir has built an ag­gres­sive clin­i­cal pro­gram …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.